DA Davidson cuts Amrize stock price target on guidance concerns
DA Davidson lowered its price target on Amrize (NYSE:AMRZ) to $40 from $50, citing concerns about fiscal 2026 guidance and the recent departure of a key executive. The stock is trading at $36.31, down 45% from its 52-week high. Multiple analysts have recently adjusted their price targets and ratings on Amrize, reflecting mixed outlooks ahead of its earnings release.
How this was made
The 30-second read
Why it matters
Analyst consensus is bearish, with several price‑target cuts and downgrades, indicating likely short‑term price weakness.
Market read
Multiple analyst downgrades and target cuts create a bearish outlook for AMRZ, likely pressuring the stock in the near term.
What to watch
Recent profitability and a possible turnaround in the standalone business could mitigate some concerns.
Background
Amrize Ltd (NYSE:AMRZ) is a building‑envelope company facing guidance and margin uncertainty after a recent executive departure.
Ticker impact
DA Davidson lowered its price target on Amrize Ltd to $40 from $50, citing guidance risk and margin uncertainty.
likely downward pressure as investors price in weaker guidance and margin concerns
Multiple analysts (DA Davidson, RBC, BofA, UBS) reduced targets, indicating consensus bearish view.
Market effects
Analyst downgrades may weigh on the broader building‑envelope and construction materials sector.
Limited to U.S. investors holding Amrize shares.
Minimal global impact beyond the stock.
Counterpoint
Barclays initiated coverage with a $55 target, suggesting potential upside if the company can improve execution.
Key entities
- analystDA Davidson
Lowered price target to $40, citing guidance risk.
- analystRBC Capital
Reduced target to $32, underperform rating.
- analystBofA Securities
Downgraded to underperform, target $40.
